Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Cisplatin in Persistent or Recurrent Squamous Cell Carcinoma of the Cervix
NCT00006482Phase 2Terminated
- Sponsor
- GOG Foundation
- Start
- Oct 2000
- Primary completion
- Apr 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of gemcitabine, cisplatin in Cervical Cancer (CC), sponsored by GOG Foundation. Started Oct 2000; status: terminated.
02
Drugs
gemcitabinecisplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00006482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006482.